: iStockAnalyst.com Symbols Feed

The Week in Review: Major Investments

Sun, 08 Nov 2009 01:33:43 GMT

Novartis made a five-year, $1 billion China commitment, building up its Shanghai R&D center and marketing efforts; Novartis will also spend $250 million to expand its global technical center in Changshu, and pay $125 million to buy a 85% stake in vaccine maker Zhejiang Tianyuan; Roche opened a new $500 million biologics manufacturing facility in Singapore; Microbix and Hunan Biopharmaceutical Co. will construct a $200 million flu vaccine facility;[More...]

ProActive HavRx Stock Indexes: Highlights And Opportunities

Sat, 07 Nov 2009 22:13:14 GMT

Below is a summary and some charts for popular and top performers among the 22 ProActive HavRx global stock indexes. Despite the FDA filing by Dendreon (NASDAQ: DNDN) during the past week, the underlying ImmunoTherapy / Vaccines Index is off to a slow start and down by about 10% since mid-October.[More...]

Wall Street Closes Higher, General Electric (NYSE: GE) Rallies

Fri, 06 Nov 2009 23:14:45 GMT

US stocks finished higher on Friday as investors shrugged off disappointing government data showing the unemployment rate hit 10.2 percent in October - the highest in 26-1/2 years.[More...]

4 Earnings Season Option Strategies For Monday November 9

Fri, 06 Nov 2009 18:31:43 GMT

In my latest three blog posts, I listed some stocks which I would be willing to go long by selling the puts right before the stock reported earnings. Keep in mind these are companies which I believed would have a positive reaction to the earnings, however if the stock moved sideways on the number this strategy would still likely return a gain the following day.[More...]

Biostar Raises $3.6 Million

Fri, 06 Nov 2009 17:26:18 GMT

Biostar Pharmaceuticals has completed a private placement that raised $3.6 million in new capital. Biostar will use the proceeds to complete its new raw materials processing facility. By taking its raw material production in house, Biostar will lower costs and ensure its product quality. Biostar plans to sell excess raw materials to other pharmaceutical companies in the Shaanxi province.[More...]

Bulls Back On Track?

Fri, 06 Nov 2009 16:21:18 GMT

Good morning. With chants of "Dow 10K… Dow 10K" once again rising from the streets at the corner of Broad and Wall yesterday, it is easy to believe that the bulls are back on track and that we'll soon be looking at new highs for the stock market. And when reviewing the data inputs to yesterday's 204 point romp, it is also easy to don the Dow10K hat once again and join in on the celebration.[More...]

Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules

Fri, 06 Nov 2009 13:52:50 GMT

Ford's 2,215 page 2007 master contract with the UAW 1941 UAW-Ford contract[More...]

King Beats, But Earnings Down

Thu, 05 Nov 2009 20:08:54 GMT

King Pharmaceuticals, Inc. (KG) reported third quarter earnings of 29 cents per share, beating the Zacks Consensus Estimate by 2 cents. Despite revenues increasing 19.3% from the year-ago period, earnings declined 25.6% from the year-ago quarter mainly due to higher operating expenses.[More...]

Options Intellignece Report : Options Activity for XRT, CVS, STT, PFE, FSYS & AEO

Thu, 05 Nov 2009 19:12:19 GMT

Today's tickers: XRT, CVS, STT, PFE, CVS, FSYS & AEO[More...]

AP IMPACT: Framed for child porn _ by a PC virus

Sun, 08 Nov 2009 16:48:00 GMT

Of all the sinister things that Internet viruses do, this might be the worst: They can make you an unsuspecting collector of child pornography.
Pranksters or someone trying to frame you can tap viruses to make it appear that you surf illegal Web sites.
Whatever the motivation, you get child porn on your computer - and might not realize it until police knock at your door.

: iStockAnalyst.com Symbols Feed

The Week in Review: Major Investments

ProActive HavRx Stock Indexes: Highlights And Opportunities

Wall Street Closes Higher, General Electric (NYSE: GE) Rallies

4 Earnings Season Option Strategies For Monday November 9

Biostar Raises $3.6 Million

Bulls Back On Track?

Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules

King Beats, But Earnings Down

Options Intellignece Report : Options Activity for XRT, CVS, STT, PFE, FSYS & AEO

AP IMPACT: Framed for child porn _ by a PC virus

Commercial real estate facing worse days

Mercury News Interview: Kevin Johnson, CEO, Juniper Networks

Watson Pharmaceuticals Q3 net income down

Mercury News Interview: Kevin Johnson, CEO, Juniper Networks

Microsoft CEO: Windows 7 Japan sales 'fantastic'

Google's 3Q lobbying costs eclipse $1 million

Google's 3Q lobbying costs eclipse $1 million

Google's 3Q lobbying costs eclipse $1 million

San Jose Mercury News, Calif., Chris O'Brien column: Who invented blogging? Answer: Nobody, really

Yahoo! to Participate at Upcoming Investor Conference

King Pharmaceuticals to Present at Credit Suisse Healthcare Conference

PicksThatMove.com Announces Investment Opinion On: Mylan Laboratories Inc., Suncor Energy Inc., Romarco Minerals Inc., Nord Resources Corporation and Eastern Platinum Limited

Celldex Therapeutics Reports Third Quarter and Nine Month 2009 Financial Results

Teva Introduces Fexofenadine HCl and Pseudoephedrine HCl Extended-Release Tablets; An Alternative to Allegra-D® 12 Hour Tablets

Merck and Schering-Plough to Complete Merger Today

Teva Reports Third Quarter 2009 Results

Bernhard Hampl, Ph.D. Elected to Serve As Executive Chairman of the Board of Directors of Fresenius Kabi Pharmaceuticals Holding, Inc.

Yahoo! Announces Open Source Distribution of Traffic Server

42 Straight Profitable Trades Keep BullTrade.Com Subscribers Happy

Form 4 Bowles Richard S III For: Nov 03 (10K)

Form 4 BARSHAY STANLEY F For: Nov 03 (10K)

Form 4 KIDDER C ROBERT For: Nov 03 (10K)

Form 4 RUSSO PATRICIA F For: Nov 03 (10K)

Form 4 Thompson Craig B. For: Nov 03 (10K)

Form 4 Merck & Co. Inc. For: Nov 03 Filed by: WENDELL PETER C (10K)

Form 4 Merck & Co. Inc. For: Nov 03 Filed by: TATLOCK ANNE M (10K)

Form 4 Merck & Co. Inc. For: Nov 03 Filed by: REPRESAS CARLOS E (10K)

Form 3 Bowles Richard S III For: Nov 03 (10K)

Form 3 BARSHAY STANLEY F For: Nov 03 (10K)